Opella Open Innovation FAQs.

Frequently Asked Questions.

Click on the questions below to see the associated answers.
 

To design the very best self-care solutions we need to look beyond our own capabilities and embrace collaboration with external partners across the industry. The Open Innovation Portal is our platform to enable this; it is our gateway for bringing the outside world in to all we do. We want to listen, learn, and lead together.

Opella is interested in receiving solutions and innovations from partners including individuals, startups, research institutions, innovative companies, and more.

The Opella Open Innovation Portal will unite the boldest and brightest external ideas with Opella's expertise, infrastructure, and reach. Innovative healthcare solution providers can benefit from Opella's research and scientific capabilities, consumer insight and marketing expertise, world-class global distribution for healthcare solutions, and expertise in legal, medical, and regulatory.

Visit our current challenges to view Opella's specific searches for disruptive healthcare solutions or new innovative consumer products. Note that Opella accepts innovations and ideas submissions beyond the currently posted challenges.

When you submit your idea through Opella's Open Innovation Portal, you will be asked to complete a "Submission Form" that includes your contact details, a non-confidential overview of your healthcare innovation or solution and your agreement to the Terms and Conditions of submission and the Privacy Notice. On behalf of Opella, yet2 will review your details and evaluate the solution within the portal.

yet2 has significant experience and understands the best approaches to reviewing technology and identifying its fit to the needs of an organization whilst ensuring adequate protection for each party. Furthermore, yet2 understands the nuances between large companies and smaller science and technology innovators and successfully manage thousands of introductions for successful partnerships each day.

yet2 will review your innovation idea submission form in relation to criteria provided by Opella's External Innovation team. yet2 will follow up directly with you through the Opella Open Innovation portal to inform you of the status of your submission.

The status of your submission to Opella's open innovation portal will be communicated within four weeks of receipt.
  • Step 1: You will receive a confirmation of receipt of your submission form via email with your personal submission identification number from yet2.
  • Step 2: An initial review will be conducted by yet2, on behalf of Opella, within approximately five working days. Once the review is completed you will be informed of your submission status via email.
  • Step 3: If yet2's initial review is positive, your submission will be further reviewed by the Opella External Innovation team. You will be informed of the status within four weeks.
  • Step 4: If the further review is positive, the Opella External Innovation team will contact you directly to discuss next steps for a potential collaboration. Additional information may be requested at this stage.
  • Step 5: Once all information has been reviewed and there is mutual consent to move forward, you and the Opella External Innovation team will potentially initiate a collaboration.

Contact information is essential to follow up. The submission form must also provide an overview of the proposed solution, with the understanding that your submission will be treated as non-confidential.

You can only submit non-confidential information. Throughout the submission process, we ask for only information that imposes no obligations of confidentiality for Opella or yet2 and does not breach any confidentiality obligations that you as the submitter owe to others. If confidential information is later required, we may negotiate a separate Confidential Disclosure Agreement or NDA prior to sharing or receiving any confidential information.

No, there will be no reward for submitting an idea or solution through this portal. However, if Opella sees potential in your submission, they would be happy to explore the opportunity further and discuss the possibility of a partnership.

Yes, these are created to protect you and your rights, as well as eliminating the risk of jeopardizing Opella ongoing research programs, projects and developing concepts.

Yes, you will have to agree to the Terms and Conditions for each submission.

Ideally, your solution will be protected by granted patents or patent applications.
 
However, Opella is willing to discuss early stage ideas before a patent filing has been made or before it has been published. If you have not filed for patents yet, you should absolutely avoid disclosing any information that jeopardizes your rights to file patents. We advise you to contact an IP lawyer prior to submission.

Yes, this is the legally-accepted age for agreeing to terms and conditions for this activity.

Please ensure that you are only using the eight character alphanumeric reference number to login. Do not include the # preceding it. Please also ensure that you are entering O (capital "o") and 0 (zero) correctly. If that fails, please contact opella@yet2.com.

Opella wants to ensure that all submitter responses are reviewed in a timely manner.
 
Furthermore, ensuring only Non-Confidential information is received eliminates the risk of jeopardizing your rights as well as those of Opella. Opella may be developing similar concepts, so sharing only Non-Confidential information is important for protecting Opella's IP position as well as your own. yet2 acts as a gatekeeper

Privacy Policy. | Terms & Conditions. | Cookie Policy.

© 2025 Opella Healthcare Group SAS.
Sanofi Consumer Healthcare business unit. All rights reserved.

Powered by
yet2